Forms of inositol
Myo-inositol, D-chiro-inositol and differences in supplement formulations.
Key points
- Myo-inositol and D-chiro-inositol are different isomers, so results for one formulation do not automatically transfer to another. When comparing supplements, check the form and component ratio on the label. [1] [2] See the evidence 1
- The international PCOS guideline does not establish a preferred type, dose or combination of inositol. Doses in individual studies should not be considered a universal regimen for all products. [1] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Different isomers and their mixtures should be compared by composition.
Key points
Why these conclusions
Isomers and doses
Myo-inositol and D-chiro-inositol are different isomers. Results for one formulation cannot automatically be transferred to another. [1] [2]
The 2023 PCOS guideline does not establish one preferred form, dose or combination of inositol; results here are tied to specific preparations and groups. [1]
Myo-inositol and D-chiro-inositol are different isomers. Results for one formulation cannot automatically be transferred to another.
Myo-inositol and D-chiro-inositol are different isomers. Results for one formulation cannot automatically be transferred to another. [1] [2]
The 2023 PCOS guideline does not establish one preferred form, dose or combination of inositol; results here are tied to specific preparations and groups.
The 2023 PCOS guideline does not establish one preferred form, dose or combination of inositol; results here are tied to specific preparations and groups. [1]
Sources
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. https://pmc.ncbi.nlm.nih.gov/articles/PMC10477934/
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. https://pmc.ncbi.nlm.nih.gov/articles/PMC11099481/
Methodology: Subpages evidence-led supplement pipeline v1